Trends in list prices, net prices, and discounts of self-administered injectable tumor necrosis factor inhibitors

BACKGROUND: List prices of tumor necrosis factor (TNF) inhibitors drastically increased during the last decade, but previous research has shown that half of these increases were offset by rising manufacturer discounts. It remains unclear to what extent manufacturers’ discounts have offset increases...

Descripción completa

Detalles Bibliográficos
Autores principales: San-Juan-Rodriguez, Alvaro, Piro, Vincent M, Good, Chester B, Gellad, Walid F, Hernandez, Inmaculada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Research Brief
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788267/
https://www.ncbi.nlm.nih.gov/pubmed/33377437
http://dx.doi.org/10.18553/jmcp.2021.27.1.112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788267/
https://www.ncbi.nlm.nih.gov/pubmed/33377437
http://dx.doi.org/10.18553/jmcp.2021.27.1.112

Ejemplares similares